Literature DB >> 2297682

Cytogenetics of thyroid follicular adenomas.

E van den Berg1, J W Oosterhuis, B de Jong, J Buist, A Vos, A Dam, B Vermeij.   

Abstract

We present the results of a cytogenetic study of three cases of follicular adenoma of the thyroid. All three cases had a numerical strongly abnormal karyotype with most abnormalities (eg, +4 or +5, +7, +9, +12, +16) in common, possibly indicating that this cluster of abnormalities might be specific for follicular adenomas. For benign tumors, the three cases showed a remarkably abnormal karyotype. These cases are another example of benign tumors with chromosomal abnormalities that might be specific for follicular adenomas.

Entities:  

Mesh:

Year:  1990        PMID: 2297682     DOI: 10.1016/0165-4608(90)90050-k

Source DB:  PubMed          Journal:  Cancer Genet Cytogenet        ISSN: 0165-4608


  5 in total

1.  Cytogenetic and molecular genetic studies of follicular and papillary thyroid cancers.

Authors:  M A Herrmann; I D Hay; D H Bartelt; S R Ritland; R J Dahl; C S Grant; R B Jenkins
Journal:  J Clin Invest       Date:  1991-11       Impact factor: 14.808

2.  A characteristic sequence of trisomies starting with trisomy 7 in benign thyroid tumors.

Authors:  G Belge; B Thode; V Rippe; S Bartnitzke; J Bullerdiek
Journal:  Hum Genet       Date:  1994-08       Impact factor: 4.132

3.  Detection of numerical alterations for chromosomes 7 and 12 in benign thyroid lesions by in situ hybridization. Histological implications.

Authors:  B Criado; A Barros; R F Suijkerbuijk; D O Weghuis; R Seruca; E Fonseca; S Castedo
Journal:  Am J Pathol       Date:  1995-07       Impact factor: 4.307

4.  Loss of heterozygosity on chromosome 1p in thyroid adenoma and medullary carcinoma, but not in papillary carcinoma.

Authors:  K Kubo; K Yoshimoto; Y Yokogoshi; M Tsuyuguchi; S Saito
Journal:  Jpn J Cancer Res       Date:  1991-10

5.  Comparison of benign and malignant follicular thyroid tumours by comparative genomic hybridization.

Authors:  S Hemmer; V M Wasenius; S Knuutila; H Joensuu; K Franssila
Journal:  Br J Cancer       Date:  1998-10       Impact factor: 7.640

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.